StemCell Technologies' Contract Services Presents Educational Webinar on Erythropoietin (EPO) Signaling and Erythroid Development

Share Article

Stem Cell Technologies (STI), a world leader in the development of technologies for stem cell biology, is pleased to announce that STI Contract Services will be providing a free, educational webinar on erythropoietin (EPO) signaling and erythroid development.

"A guide to erythropoiesis: EPO signaling and erythroid development", will be presented by Dr. Jackie Damen on March 12, 2008 at 11:00 a.m. PST (2:00 p.m. EST). Register online by visiting

The 45-minute webinar will focus on the following topics:

  •     An overview of erythropoiesis and erythropoietin (EPO) biology;
  •     Mechanisms of EPO-receptor signaling; and
  •     In vitro and in vivo assays used to determine the functional activity of EPO.

About Stemcell Technologies Inc. Contract Services
StemCell Technologies is a world leader in the development of products for hematopoietic stem cell biology and has worked to standardize the field through the Global Proficiency Testing Program. Combining StemCell Technologies' industry standard reagents and a scientific team of experts in hematopoiesis and stem cell biology, the Contract Services team is proud to assist organizations in all areas of the biopharmaceutical industry by offering their skills and expertise in performing stem cell assays.

About Dr. Jackie Damen
Following completion of her PhD (1990) at the University of Manitoba, Jackie performed her post-doctoral training at the Terry Fox Laboratory in Vancouver BC. There she characterized signal transduction pathways downstream of the mouse eyrthropoietin receptor, discovering key regulatory mechanisms of the pathway which resulted in several first author publications. She also identified and studied the role of a novel signaling intermediate involved in the regulation of many hematopoietic pathways.

Dr. Damen then joined Chemokine Therapeutics as Director of Biology and initiated studies using mouse models to investigate hematopoietic modulation in response to synthetic compounds. She joined StemCell Technologies in January, 2002 and is currently using her knowledge of hematopoiesis to assist the biopharmaceuticals industry as the Director of Contract Assay Services at StemCell Technologies

Dr. Damen has authored numerous scientific papers and is a frequent speaker and presenter at national and international meetings.

Dr. Jackie Damen
Director, STI Contract Services

# # #

Share article on social media or email:

View article via:

Pdf Print